mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.7 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.7 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |